Beverley Clary, MD
Obstetrics & Gynecology · Richmond, VANPI 1528028305
Payments from drug & device makers
Across 168 payments — averaging $27.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$847
- Sumitomo Pharma America, Inc.$646
- Astellas Pharma US Inc$530
- Axonics, Inc.$526
- AbbVie$307
- Coloplast$208
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$1142%
- Travel & lodging$4009%
- Food & beverage$3,80983%
- Education$2796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $847 |
| Sumitomo Pharma America, Inc. | 26 | $646 |
| Astellas Pharma US Inc | 20 | $530 |
| Axonics, Inc. | 9 | $526 |
| AbbVie(2 entities) | 14 | $307 |
| Coloplast | 9 | $208 |
| Pfizer | 10 | $145 |
| Boston Scientific | 1 | $121 |
| Bayer | 6 | $109 |
| Johnson & Johnson | 1 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $90 |
| Amgen | 4 | $72 |
| Novo Nordisk | 4 | $71 |
| Exeltis, USA Inc. | 4 | $67 |
| Coopersurgical, Inc. | 4 | $61 |
| Therapeuticsmd, Inc. | 4 | $61 |
| Hologic Sales And Service, LLC | 3 | $59 |
| Mayne Pharma Commercial LLC | 5 | $56 |
| Vertex | 3 | $56 |
| Covidien LP | 4 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Merck | 3 | $45 |
| Bausch Health US, LLC | 3 | $42 |
| Millicent US Inc | 2 | $35 |
| Ambu Inc. | 1 | $31 |
| AMAG Pharmaceuticals, Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Organon | 1 | $20 |
| Medtronic | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $15 |
| Renovia Inc | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Lupin Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$768
- Axonics$177
- GENERAL FEMALE SUI$121
- GEMTESA$114
- STRATAFIX$108
- Enseal$108
- Harmonic$108
- EVICEL Fibrin Sealant (Human)$108
How this compares
$4,602 in reported general payments places this provider in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 130 | $107,990 |
| MyrbetriqMirabegron | 63 | $67,040 |
| OzempicSemaglutide | 40 | $51,928 |
| PremarinEstrogens, Conjugated | 70 | $31,554 |
| Estradiol | 327 | $14,634 |
| PremproEstrogen,con/M-Progest Acet | 17 | $11,562 |
| ImvexxyEstradiol | 21 | $8,712 |
| TrulancePlecanatide | 13 | $7,253 |
| Trospium Chloride ErTrospium Chloride | 34 | $4,880 |
| NitrofurantoinNitrofurantoin Macrocrystal | 121 | $4,382 |
| Estradiol (Twice Weekly)Estradiol | 34 | $3,514 |
| ValacyclovirValacyclovir Hcl | 50 | $2,123 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 100 | $1,405 |
| Clobetasol Propionate | 42 | $1,286 |
| ProgesteroneProgesterone, Micronized | 33 | $1,126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $646 | $107,990130 claims |
| Astellas Pharma US IncMyrbetriq | $530 | $67,04063 claims |
| Novo NordiskOzempic | $71 | $51,92840 claims |
| PfizerPremarin, Prempro | $145 | $43,11687 claims |
| Therapeuticsmd, Inc.Imvexxy | $61 | $8,71221 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $90 | $7,25313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Richmond
- Samuel CampbellRichmond$1.5M
- Prescott PrillamanRichmond$329K
- John PartridgeRichmond$216K
- James JonesRichmond$134K
- Ramzi AboujaoudeRichmond$94K
- Nicole KarjaneRichmond$34K
- Lauren SiffRichmond$16K
- Joseph HaddadRichmond$13K
- Christina IsaacsRichmond$11K
- Frances CaseyRichmond$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.